This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Harvard Bioscience Inc (HBIO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 25.77M 20.68M 17.92M 19.70M
Receivables 17.66M 18.98M 17.58M 17.59M
Inventories 15.78M 17.76M 18.16M 15.83M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 60.75M 58.97M 57.56M 58.57M
Property, Plant & Equipment, Gross 18.82M 17.86M 13.38M 13.16M
Accumulated Depreciation & Depletion 14.44M 13.31M 10.30M 10.01M
Property, Plant & Equipment, Net 4.38M 4.55M 3.09M 3.15M
Intangibles 20.30M 22.50M 23.64M 23.18M
Other Non-Current Assets 316.00K 490.00K 215.00K 360.00K
Total Non-Current Assets 74.71M 74.51M 69.07M 66.23M
Liabilities & Shareholder Equity
Total Assets 135.46M 133.48M 126.63M 124.80M
Accounts Payable 4.68M 4.68M 4.96M 4.92M
Short Term Debt 5.00M 0.00 0.00 0.00
Other Current Liabilities 685.00K 1.23M 794.00K 1.23M
Total Current Liabilities 16.08M 9.90M 9.56M 11.30M
Long Term Debt 19.75M 12.95M 16.30M 18.01M
Deferred Income Taxes 160.00K 277.00K 369.00K 954.00K
Other Non-Current Liabilities 4.98M 6.14M 4.91M 4.29M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 24.89M 19.37M 21.58M 23.25M
Total Liabilities 40.98M 29.27M 31.14M 34.55M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 94.48M 104.21M 95.50M 90.25M
Common Par 390.00K 370.00K 362.00K 361.00K
Additional Paid In Capital 202.45M 196.63M 191.16M 187.89M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -95.04M -77.26M -79.63M -83.44M
Treasury Stock -10.67M -10.67M -10.67M -10.67M
Other Equity Adjustments -2.64M -4.86M -5.72M -3.90M
Total Capitalization 114.24M 117.16M 111.80M 108.26M
Total Equity 94.48M 104.21M 95.50M 90.25M
Total Liabilities & Stock Equity 135.46M 133.48M 126.63M 124.80M
Total Common Shares Outstanding 31.64M 29.38M 28.54M 28.31M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 7.75M 7.75M 7.75M 7.75M
Basic Weighted Shares Outstanding 30.38M 28.80M 28.45M 28.97M
Diluted Weighted Shares Outstanding 31.91M 29.42M 29.82M 29.40M
Number of Employees 345 398 375 368
Number of Part-Time Employees 23 24 21 21
HBIO News

HBIO Harvard Bioscience Inc

Analysts Ratings for HBIO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET HBIO ANALYST REPORT

Brokerage Partners

HBIO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs